Evidence map›Paper›PMID 37708233›Full record

ArticlePloS one2023

Sustainable supplier selection based on VIKOR with single-valued neutrosophic sets.

Xiaochun Luo, Zilong Wang, Liguo Yang, Lin Lu, Song Hu

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Heliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaochun LuoCollege of Economics and Management, Nanjing University of Aeronautics and Astronautis, Nanjing, China.
Zilong WangCollege of Economics and Management, Nanjing University of Aeronautics and Astronautis, Nanjing, China.
Liguo YangSchool of Business, Hohai University, Nanjing, China.
Lin LuSchool of Economics and Management, Guangxi Normal University, Guilin, China.ORCID 0000-0002-5143-2773
Song HuSchool of Economics and Management, Guangxi Normal University, Guilin, China.ORCID 0000-0002-6612-0094

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering economic, environmental, and social issues, the sustainability of the supply chain has drawn considerable attention due to societal and environmental changes within the supply chain network. The strategic study of the entire supply chain process and maximizing an organization's competitive advantage depend heavily on supplier selection based on sustainable indicators. Selecting sustainable suppliers for the supply chain is challenging since it is a multi-criteria decision-making (MCDM) problem with significant uncertainty in the decision-making process. This study uses the VlseKriterijumska Optimizacija I Kompromisno Resenje (VIKOR) technique and single-valued neutrosophic sets (SVNS) to deal with the challenge of choosing a sustainable supplier with insufficient information. This method reduces the influence of personal experience and preference on the final evaluation results and the problem of excessive individual regret caused by factor correlation and improves the consistency of evaluation results. Finally, the method's success and adaptability are demonstrated by sensitivity analysis and additional comparison analysis, and the benefits and drawbacks of the suggested framework are examined. Compared to other approaches, it can assist decision-makers in communicating fuzzy and uncertain information, offering a perspective and approach for MCDM in the face of such situations, and helping them select suppliers of high caliber and who practice sustainable business practices.

Indexed as

AntibodiesCommerceEmotionsUncertaintyAntibodies

Identifiers

PMID37708233
PMCPMC10501681

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.